Identification and pathogenicity of an XDR Streptococcus suis isolate that harbours the phenicol-oxazolidinone resistance genes optrA and cfr, and the Bacitracin (cas 1405-87-4) resistance locus bcrABDR
-
Add time:09/29/2019 Source:sciencedirect.com
ABSTRACTOne hundred and seven Streptococcus suis isolates were collected from healthy pigs or asymptomatic carriers in Jiangsu, China in 2016–2017. Thirty-eight percent of the isolates were linezolid-resistant and all carried the optrA gene. Among them, one isolate, SFJ44, was resistant to all 20 of the antibiotics tested, except for ceftiofur, and thus exhibited an extensively-drug-resistant phenotype. This isolate carried the optrA gene and the Bacitracin (cas 1405-87-4) resistance locus bcrABDR on an antibiotic-resistance-associated genomic island (ARGI1), and harboured the resistance genes cfr, aadE, sat4, spw-like, aphA3, mef(A), msr(D), erm(A)-like, erm(B), tetAB(P)', tet(M) and catQ on ARGI2∼4. The IS1216E-bcrABDR-ISEnfa1 segment showed >99.9% sequence identity to corresponding sequences from other species. The cfr gene was located on ARGI4, and two IS6 family insertion sequences, IS1216E and ISTeha2, were found upstream and downstream of cfr-ΔISEnfa5, respectively. A circular intermediate of bcrABDR-ISEnfa1 was detected, suggesting the role of ISEnfa1 in dissemination of bcrABDR. Other antibiotic resistance genes might be acquired from different Gram-positive pathogens. Infection of zebrafish showed that SFJ44 exhibited a virulence level comparable to serotype 2 hypervirulent strain SC070731, highlighting the need for surveillance of the pathogenicity of multi-drug-resistant S. suis isolates. This is the first report of the co-existence of optrA and cfr, and of the bcrABDR locus in streptococci. As it has been suggested that S. suis may act as an antibiotic resistance reservoir contributing to the spread of resistance genes to major streptococcal pathogens, the potential dissemination of these resistance genes among Gram-positive bacteria is of concern and routine surveillance should be strengthened.
We also recommend Trading Suppliers and Manufacturers of Bacitracin (cas 1405-87-4). Pls Click Website Link as below: cas 1405-87-4 suppliers
Prev:Incorporation of Bacitracin (cas 1405-87-4) in Langmuir films of phospholipids at the air-water interface
Next:Facile synthesis of Bacitracin (cas 1405-87-4)-templated palladium nanoparticles with superior electrocatalytic activity) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Facile synthesis of Bacitracin (cas 1405-87-4)-templated palladium nanoparticles with superior electrocatalytic activity09/30/2019
- Incorporation of Bacitracin (cas 1405-87-4) in Langmuir films of phospholipids at the air-water interface09/28/2019
- ProtocolsImmobilizing Bacitracin (cas 1405-87-4) on titanium for prophylaxis of infections and for improving osteoinductivity: An in vivo study10/01/2019
- Bacitracin (cas 1405-87-4) promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by stimulating the bone morphogenetic protein-2/Smad axis09/27/2019
- Self-assembly of Bacitracin (cas 1405-87-4)-gold nanoparticles and their toxicity analysis09/26/2019
- Original ArticleUntangling the transcription regulatory network of the Bacitracin (cas 1405-87-4) synthase operon in Bacillus licheniformis DW209/25/2019
- Short CommunicationAntioxidant-based synergistic eradication of methicillin-resistant Staphylococcus aureus (MRSA) biofilms with Bacitracin (cas 1405-87-4)09/24/2019
-
Health and Chemical more >